Clinical Trial: A Study on the Optimization of Tacrolimus Dosage Strategies for Hematopoietic Stem Cell Transplant Patients Using Machine Learning (China)

China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Optimization of Tacrolimus Dosage Strategies for Hematopoietic Stem Cell Transplant Patients Using Machine Learning'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133638

Registration Time: 2026/09/29

Type: Interventional study

Primary Sponsor: Zhejiang Provincial People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344205

Published by HT Digital Content Services with permission from Health Daily Digest....